pediatric oncology

Pediatric high-grade glioma is not one tumor type but manyStratifying tumors by their clinical characteristics and underlying biology will enable future targeting of specific therapies for glioma in children.
Personalized and costly, but new ALL treatment offers hopeA new customized therapy for acute lymphoblastic leukemia (ALL) offers high remission rates but at a substantial cost, and only at specialized cancer centers.
The price of surviving childhood cancerSurviving cancer is challenging enough, but now a recent report highlights the fact that survivors face double the chronic health challenges of the general population as a result of curative cancer therapies.
FDA expands ipilimumab approval to pediatric melanomaThe US Food and Drug Administration (FDA) has expanded the approval of ipilimumab (Yervoy) to include the treatment of pediatric melanoma patients 12 years and older with unresectable or metastatic disease.
Why do so many kids die so soon following a cancer diagnosis?While improvements have been made to childhood cancer mortality rates, a recent research study aims to identify how many children die before being able to start treatment, and what interventions can be put in place to improve their chances.
Boy with ear pain and facial weaknessA 13-year-old boy with poorly controlled type 1 diabetes (T1D) presents to the emergency department (ED) for evaluation of left ear pain and left facial weakness.
Reimagineering chemotherapyFun isn’t what you’d typically expect in a chemotherapy infusion room. Yet, that’s precisely the environment an adolescent and young adult oncologist and a former Disney Imagineer created with the Infusionarium concept.
Evaluate thyroid nodules for possible cancerThyroid cancer is one of the most frequently diagnosed cancers in pediatric patients. Here's practical information on diagnosing and managing a child with new thyroid nodules.
Rash treatment can have long-term implicationsTreating a rash in a pediatric patient undergoing cancer therapy can have long-term health implications.
Phase I clinical trials test new therapies for kids’ cancersEarly phase pediatric cancer trials offer hope to children whose cancer defies standard therapy.